In: Current Oncology Reports, 2021, vol. 23, no. 3, p. 10
Purpose of Review Richter syndrome (RS) is an uncommon but aggressive evolution of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). RS is an unmet clinical need in the field of CLL. Recent advances in understanding the biology of this condition provide the rationale for testing new therapeutic concepts in order to improve the outcome of patients developing RS, which is so far...
|
In: Journal of Hematopathology, 2015, vol. 8, no. 1, p. 13-20
|
In: The Journal of Clinical Endocrinology & Metabolism, 2018, vol. 103, no. 6, p. 2189-2198
|
In: Cancers, 2020, vol. 12, no. 7, p. 17 p
Diffuse large B cell lymphoma (DLBCL) is a heterogenous disease that has been distinguished into at least two major molecular entities, the germinal center-like B cell (GCB) DLBCL and activated-like B cell (ABC) DLBCL, based on transcriptome expression profiling. A recurrent ch11q24.3 gain is observed in roughly a fourth of DLBCL cases resulting in the overexpression of two ETS transcription...
|
In: Non-coding RNA, 2019, vol. 5, no. 3, p. 47
Diffuse large B-cell lymphoma (DLBCL), marginal zone lymphoma (MZL) and follicular lymphoma (FL) are the most common B-cell lymphomas (BCL) in dogs. Recent investigations have demonstrated overlaps of these histotypes with the human counterparts, including clinical presentation, biologic behavior, tumor genetics, and treatment response. The molecular mechanisms that underlie canine BCL are...
|
In: Virchows Archiv, 2014, vol. 464, no. 6, p. 735-741
|
In: Current Treatment Options in Neurology, 2014, vol. 16, no. 1, p. 1-14
|
In: Oncotarget, 2017, vol. 8, no. 49, p. 85068-85084
Diffuse large B cell lymphoma (DLBCL) is the most frequent lymphoma accounting for more than the 30% of the cases. Involvement of extranodal sites, such as bone marrow and central nervous system, is associated with poor prognosis. A contribution of the chemokine system in these processes is assumed as it is known as a critical regulator of the metastatic process in cancer. The atypical...
|
In: Virchows Archiv, 2006, vol. 449, no. 3, p. 328-333
|
In: Annals of Hematology, 2010, vol. 89, no. 8, p. 783-787
|